Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain

European Journal of Pharmacology
N M Nicolaou

Abstract

The effects of chronic neuroleptic treatment on the concentrations of homovanillic acid (HVA) and 3,4-dihydroxy-phenylacetic acid (DOPAC) in the rat substantia nigra (SN) and corpus striatum (CS) were determined. Acute haloperidol and alpha-flupenthixol increased HVA and DOPAC in the CS but after chronic treatment no significant change was found compared to controls. In the SN, on the contrary, acute haloperidol reduced and subsequently increased HVA and DOPAC and alpha-flupenthixol had no significant effect, whereas chronic treatment with either neuroleptic increased the levels of the metabolites. Acute apomorphine reduced HVA and DOPAC in CS, but increased first and subsequently decreased the levels of the metabolites in the SN. Acute amphetamine reduced both metabolites in SN and DOPAC in CS, whereas striatal HVA was unaffected. The different or even reciprocal effects on DA release may suggest an independent local action of these drugs in CS and SN.

References

Mar 14, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·G K Aghajanian, B S Bunney
Nov 7, 1975·Science·P M GrovesG V Rebec
Jan 1, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·A ArgiolasG L Gessa
Jan 27, 1977·Nature·M Garcia-MunozG W Arguthnott
Sep 22, 1977·Nature·A NieoullonJ Glowinski
Dec 1, 1976·Journal of Neurochemistry·P F SpanoM Trabucchi
Feb 1, 1975·European Journal of Pharmacology·S WilkB Travis
Mar 18, 1976·Nature·J KorfB H Westerink
Mar 18, 1976·Nature·L B GeffenL L Iversen
Sep 1, 1974·The Journal of Pharmacy and Pharmacology·J Christiansen, R F Squires
Oct 31, 1973·Nature: New Biology·D Tarsy, R J Baldessarini
Sep 1, 1967·European Journal of Pharmacology·H CorrodiT Hökfelt

❮ Previous
Next ❯

Citations

May 20, 1988·European Journal of Pharmacology·U SpampinatoM Hamon
Apr 1, 1992·Pharmacology, Biochemistry, and Behavior·R K Schwarting, J P Huston
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·M L AizensteinR Delucia
Mar 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J MosB Olivier
Dec 15, 2000·Progress in Neurobiology·T M Tzschentke
Jan 1, 1997·Journal of Psychopharmacology·M B Knable, D R Weinberger
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Janne LähdesmäkiMika Scheinin
Nov 7, 2013·The Cochrane Database of Systematic Reviews·Meghana Mothi, Stephanie Sampson
Feb 1, 1987·The Journal of Pharmacy and Pharmacology·P Soares-da-Silva
Jul 24, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Matthieu GasnierPierre Abdel Ahad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here